CLEVELAND – Nathan Levitan, MD, MBA, has been appointed President of the University Hospitals Ireland Cancer Center (ICC) and Senior Vice President, System Cancer Services, effective November 1, 2008.

In his new role, Dr. Levitan is responsible for cancer-related clinical program development, quality outcomes, strategic planning, and the ongoing integration of clinical trials into the ICC model of care. While working in close collaboration with Stanton Gerson, MD, Director of the Ireland Cancer Center, Dr. Levitan will oversee the continued growth of our ICC Regional Network as well as the consolidation of cancer services at UH Case Medical Center into the new UH Cancer Hospital that is scheduled to open in 2010.

“Nathan has played key roles as an administrator and clinician within University Hospitals and the Ireland Cancer Center for 15 years and we are pleased to have him now lead our cancer program,” says Fred C. Rothstein, MD, President, UH Case Medical Center. “Dr. Levitan’s wealth of experience will help further our nationally renowned cancer programs and research as well as the transition to the new Cancer Hospital being built at UH Case Medical Center.”

Prior to this appointment, Dr. Levitan held concurrent positions as Senior Vice President of UH Case Medical Center, Chief Medical Officer of University Hospitals, and Interim Chairman of the Department of Radiation Oncology.  He has also served in a variety of clinical oncology and administrative capacities at UH since 1993, including Medical Director of Clinical Cancer Programs for ICC.

He is a nationally recognized lung cancer expert and helped to lead the ICC’s lung cancer program to great renown. A native of Massachusetts, Dr. Levitan received his MD from Tufts University School of Medicine and completed his hematology/oncology training at Boston Veterans Administration Medical Center and the University of Massachusetts Medical Center.  He received his MBA from Case Western Reserve University.

Dr. Levitan is board certified in internal medicine, medical oncology and hematology and also serves as Professor of Medicine at Case Western Reserve University School of Medicine.

Also effective November 1 is the appointment of Michael R. Anderson, M.D. as Interim Chief Medical Officer, University Hospitals. Dr. Anderson is currently Associate Chief Medical Officer and a practicing physician at UH Rainbow Babies & Children’s Hospital.